Mark Pomeranz - Motus GI NonIndependent CEO

MOTSDelisted Stock  USD 0.65  0.02  2.99%   

CEO

Mr. Mark Pomeranz appointed as President, Chief Operating Officer, Director of the Company., effective October 1, 2018. He was Chief Executive Officer and Director of the Company. Mr. Pomeranz was Chief Executive Officer of Opco since 2014 and has served as our CEO since the Share Exchange Transaction. Prior to joining Opco, from 2007 to 2014, Mr. Pomeranz was the founding CEO of Svelte Medical Systems, a startup company that is currently commercializing a unique drug eluting stent platform in the EU. From 1998 to 2007, Mr. Pomeranz served as Vice President at Cordis, a Johnson Johnson Company, where his responsibilities included developing new technologies, exploring new market opportunities and leading major restructuring efforts to create crossfunctional global commercialization teams. Prior to that, Mr. Pomeranz held a number of senior leadership roles, including positions at Cardiac Pathways Corporationrationrations from 1991 to 1998, and Cardiovascular Imaging Systems from 1989 to 1991, both of which were acquired by Boston Scientific Corporationrationration. Mr. Pomeranz earned a M.Sc. in biomedical engineering from the University of Miami. since 2018.
Age 62
Tenure 6 years
Phone954 541 8000
Webhttps://www.motusgi.com

Motus GI Management Efficiency

The company has return on total asset (ROA) of (0.5985) % which means that it has lost $0.5985 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5434) %, meaning that it created substantial loss on money invested by shareholders. Motus GI's management efficiency ratios could be used to measure how well Motus GI manages its routine affairs as well as how well it operates its assets and liabilities.
Motus GI Holdings currently holds 2.47 M in liabilities with Debt to Equity (D/E) ratio of 3.04, implying the company greatly relies on financing operations through barrowing. Motus GI Holdings has a current ratio of 4.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Motus GI until it has trouble settling it off, either with new capital or with free cash flow. So, Motus GI's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Motus GI Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Motus to invest in growth at high rates of return. When we think about Motus GI's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CEO Age

Alex OvadiaCheck Cap
62
David DomzalskiVyne Therapeutics
57
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida. Motus Gi operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 30 people. Motus GI Holdings [MOTS] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Motus GI is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

Motus GI Holdings Leadership Team

Elected by the shareholders, the Motus GI's board of directors comprises two types of representatives: Motus GI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Motus. The board's role is to monitor Motus GI's management team and ensure that shareholders' interests are well served. Motus GI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Motus GI's outside directors are responsible for providing unbiased perspectives on the board's policies.
Elad Amor, Chief Officer
Mark Pomeranz, NonIndependent CEO
Timothy Moran, CEO, Director
Andrew MBA, Chief Officer
Scott Aldrich, VP Strategy
Ravit Ram, CFO Operations

Motus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Motus GI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in Motus OTC Stock

If you are still planning to invest in Motus GI Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Motus GI's history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data